Client News
Filter by:
- Feb 26 2024 Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Feb 22 2024 Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
- Feb 22 2024 Ispire, Berify and Chemular to Propel Innovation in Vape Hardware Manufacturing Industry
- Feb 22 2024 Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium
- Feb 21 2024 Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
- Feb 21 2024 Sonim Set to Seize Market Opportunity Amidst Bullitt Exit
- Feb 15 2024 Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
- Feb 14 2024 Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
- Feb 12 2024 Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
- Feb 5 2024 Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting